To explore whether CRISPR can mediate both events in vivo, we targeted a 50 kb region of the mouse genome encompassing the first four exons of the Pten [32] gene, a region frequently deleted in liver cancer [33] (Fig. 5a, b). Here, PTEN is linked to liver cancer.